Clinical Trials Directory

Trials / Unknown

UnknownNCT06181682

Intranasal Dexmedetomidine Versus Intranasal Midazolam as a Premedication in Pediatrics Undergoing Upper GI Endoscopy

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
2 Years – 6 Years
Healthy volunteers
Accepted

Summary

compare the effectiveness of intranasal dexmedetomidine and midazolam as a premedication in sedation of preschool children in GI endoscopy

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineIntranasal Dexmedetomidine
DRUGMidazolamIntranasal midazolam

Timeline

Start date
2024-01-01
Primary completion
2024-03-01
Completion
2024-03-01
First posted
2023-12-26
Last updated
2023-12-26

Regulatory

Source: ClinicalTrials.gov record NCT06181682. Inclusion in this directory is not an endorsement.

Intranasal Dexmedetomidine Versus Intranasal Midazolam as a Premedication in Pediatrics Undergoing Upper GI Endoscopy (NCT06181682) · Clinical Trials Directory